Eikon Therapeutics, Inc. EIKN Accounts Payable and Accrued Liabilities, Current
Accounts Payable and Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.
The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eikon Therapeutics, Inc. 's accounts payable and accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eikon Therapeutics, Inc. 's accounts payable and accrued liabilities, current?
- Eikon Therapeutics, Inc. (EIKN) reported accounts payable and accrued liabilities, current of $29.32M in Q1 2026.